Alembic Pharma | APLLTD | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Revenue
Revenue
39,34746,05854,03153,56356,554
Cost of revenue
Cost of revenue
-9,927-10,394-12,573-14,464-17,088
Gross Profit
Gross Profit
29,420
35,664
41,458
39,098
39,465
Sales, general & ad...
Sales, general and administrative
-20,684-23,433-25,782-29,852-32,355
Depreciation
Depreciation and amortization
-1,152-1,573-1,835-2,868-2,754
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
7,584
10,657
13,841
6,379
4,357
 
      
Profit before tax
Profit before tax
7,4939,99813,6816,2543,546
Net Income
Net income
5,844
8,288
11,781
5,209
3,420
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
31.00
43.97
60.81
26.50
17.40